WANA (Sep 20) – For the first time in Iran, a specialized drug has been developed to control and slow the progression of pulmonary fibrosis, helping patients breathe more easily by reducing lung inflammation.
Pulmonary diseases such as…
WANA (Sep 20) – For the first time in Iran, a specialized drug has been developed to control and slow the progression of pulmonary fibrosis, helping patients breathe more easily by reducing lung inflammation.
Pulmonary diseases such as…